ICICI Securities Initiate coverage on Niva Bupa with Buy rating; with target price of Rs 90 basis 35 times FY27E earnings per share of Rs 2.6 (IFRS)
(Photo source: Envato)
Niva Bupa has been able to deliver standout growth in health insurance premiums (~40% CAGR between FY20-25) while its improved scale and assets under management should help improve margins and earnings growth ahead (expect IFRS PAT CAGR of 53% over FY25-27E). The relative high growth could continue driven by diversified channel which in turn creates positive flywheel on loss ratios, especially when players across industry including N...